Grantors & Exhibitors
We thank the following Grantors and Exhibitors for their support in helping to make this conference possible.
Fraud Investigation & Dispute Services, Life Sciences team
Industry insight and global experience: the intelligent connection
Tighter competition, regulatory scrutiny and tough enforcement heighten the risk of litigation and non-compliance. In your industry, compliance issues and risk factors need to be addressed at every turn from research and development to marketing strategies and supply chain integrity. And the scrutiny of regulators and customers alike is increasing and rapidly changing.
Our professionals understand the complex issues facing pharmaceutical, biotechnology and medical device companies. By making the intelligent connection between your business operations, markets and third-party relationships, we can help you get to the root cause of problems arising from impropriety. Our dedicated team includes CPAs, government contract analysts, economists, licensed pharmacists and certified fraud examiners, as well as former pharmaceutical executives, ethics and compliance officers and government auditors, investigators and prosecutors.
For more information visit www.ey.com/fids or contact:
Ted Acosta, Partner, Fraud Investigation & Dispute Services +1 212 773 3022 (email@example.com)
Mariusz Witalis, Partner, Fraud Investigation & Dispute Services +48 22 557 7950 (Mariusz.Witalis@pl.ey.com)
Rajiv Joshi, Partner, Fraud Investigation & Dispute Services +91 22 61921569 (firstname.lastname@example.org).
Polaris, a QuintilesIMS company, is the world’s leading healthcare compliance software and consulting firm, providing innovative solutions to Life Sciences companies.
Our services range from best-in-class compliance software to expert consulting, planning and strategic guidance from the industry’s leading compliance authorities. Polaris also offers competitive data analytics and end-to-end managed services.
Polaris is headquartered in New York City, with worldwide offices in Amsterdam, Boston, Hong Kong, New Brunswick, Paris and San Francisco.
Since 2001, the world’s most recognized pharmaceutical, biotech and medical device companies have relied on Polaris as their trusted life sciences compliance solutions partner. Learn more at www.polarismanagement.com.
PwC’s pharmaceutical, biotech and medtech specialists work with clients to define and deliver effective solutions to the complex challenges affecting businesses in all areas from innovation to regulation and patient engagement. We’re part of a network of firms in 157 countries with more than 223,000 people who are committed to delivering quality in assurance, advisory and tax services.
Find out more and tell us what matters to you by visiting us at: https://www.pwc.co.uk/pharmaceuticals-life-sciences
Our lawyers have acted as trusted advisers to the world’s largest healthcare companies for more than half a century. Among the first firms to provide comprehensive industry advice — covering biopharmaceuticals, medical devices, and healthcare services — we have broad experience and a sophisticated understanding of the global life sciences market that few can match. We help healthcare companies soundly navigate intensifying legal and commercial risks, realize opportunities for expansion and growth, and stay ahead of the innovation curve.
Our international network spans 47 countries, including the largest healthcare markets in the world. Many of our practices — including M&A, Tax, Compliance, Healthcare Regulatory, Employment, Intellectual Property, and Dispute Resolution — are ranked among the world’s leading. Our lawyers have developed a depth of knowledge in the industry in respect of various market players including manufacturers, distributors, research institutions, clinical trial bases and health and regulatory authorities. For more information www.BakerMcKenzie.com.
Those of us in the Davis Wright Tremaine health care practice group devote nearly all of our time to industry-specific matters. This allows us to develop niche practices within the field that serve needs unique to the health care market. We also understand the business issues and regulatory developments that affect health care delivery and compliance, and as a unified team we can match the attorney with the niche expertise that best addresses client needs. For more information visit our website at www.DWT.com.
Celebrating more than 130 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 1000 lawyers in 20 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, for uncompromising commitment to quality and for dedication to understanding the business and culture of its clients. King & Spalding was recently chosen by Law360 and U.S. News & World Report as the “Law Firm of the Year” for FDA law and LMG Life Sciences selected the firm as one of the finalists for “Regulatory Firm of the Year.”
For more information about our FDA & Life Sciences practice, please contact Mark Brown at (202) 626-5443. www.kslaw.com
Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global professional services firm that helps clients take control of their future. Our life sciences and healthcare consultants help you navigate the complex regulatory environment of Pharmaceutical, Biotech, Medical Device and Diagnostics industries, we apply our deep industry knowledge, technical expertise, and strategic approach to offer solutions and deliver powerful results. From the synthesis of highly complex transactions, rules, regulations, data, documents and business practices to bring meaningful value to the co-development of a dispute, regulatory, compliance or investigation strategy and execution, we help clients help clients build, manage, and protect their business interests.
More information about Navigant can be found at www.navigant.com.
Paul Hastings provides innovative compliance and legal solutions to many of the world’s top pharmaceutical and life sciences companies, large and small, in markets across Asia, Europe, Latin America, and the United States. We offer a complete portfolio of services to support our clients’ complex, often mission-critical needs–from structuring transactions, to protecting critical intellectual property, to resolving complicated U.S. healthcare and global anti-corruption enforcement matters, to providing the savvy compliance and legal counsel that keeps business moving forward.
Paul Hastings has grown steadily and strategically along with our clients across global markets in the critical pharmaceutical and life sciences sector. We have a significant and strategic presence across Europe, and were one of the first U.S. law firms to establish a presence in Asia, where we continue to be a leader in the region, and have significantly expanded our support for clients in Brazil, out of our new São Paulo office, and other emerging markets of Latin America.
More information can be found at www.PaulHastings.com.
Porzio Life Sciences helps pharmaceutical, medical device and biotechnology companies satisfy federal, state and ex-US marketing and sales obligations. Our best-in-class compliance solutions include: the Porzio Compliance Digest, with real-time databases of enacted laws, pending legislation and government enforcement actions; Porzio AggregateSpendID®, which tracks and reports healthcare provider and organization expenditures; and Porzio GST®, which enables companies to capture and manage data for meeting reporting obligations in almost 40 ex-US jurisdictions. Further, Porzio Life Sciences provides compliance services, such as assistance with acquiring and maintaining distribution licenses. For information, visit www.porziolifesciences.com.
Sidley’s global life sciences practice comprises a team of multidisciplinary lawyers with a deep understanding of the issues innovators face—from the science and technology to the business realities. Harnessing a breadth of experience, we represent prominent pharmaceutical, biotechnology, medical device, dietary supplements and food clients on a range of regulatory, compliance and enforcement issues. Strong advocacy on behalf of our clients consistently earns our team acknowledgement from industry publications. This includes having won LMG Life Sciences’ “Regulatory Firm of the Year”, for the fifth year in a row. We also received first-tier national rankings in Biotechnology Law, FDA Law and Healthcare Law in the U.S. News — Best Lawyers® “Best Law Firms” rankings for the eight consecutive year, and each year since the survey’s inception. In addition, our service and responsiveness earned us recognition in the BTI Industry Power Rankings as a “Most Recommended Law Firm in the Pharmaceutical Industry.”
For more information please visit www.Sidley.com.
Created in 2004, BMI SYSTEM is the only French software publisher dedicated to comply and manage transparency, compliance and data protection regulatory requirements.
We aim to be recognised as an independent international association of professionals, which sets standards of Ethics and Compliance and shapes and influences strategies in the changing Healthcare environment for the ultimate benefit of Patients and Society at large.
— We are a visible and transparent network and a think tank of diverse International Ethics and Compliance professionals in the Healthcare sector
— We add sustainable value to Ethics and Compliance professionals enabling them to manage their professional responsibilities and supporting them in their career development
— We develop and share best practices to anticipate and facilitate new business models in the healthcare sector including through effective education and training, closer collaboration between MedTech and Pharma and other initiatives
— We deliver Ethics and Compliance perspectives to external Healthcare sector stakeholders, as well as to Ethics and Compliance professionals from other sectors
— We are an independent, not-for-profit association governed by a Code of Conduct.
Seton Hall Law’s Center for Health & Pharmaceutical Law & Policy advances scholarship and recommendations for policy on the varied and complex issues posed by health and pharmaceutical law. As a nationally ranked Health Law program, the Center fosters informed dialogue between policymakers, consumer advocates, the medical profession, and industry in the search for solutions to the ethical, legal, and social questions presented in the health and pharmaceutical arena.
In addition, the Center is a leader in providing healthcare compliance education and training in the U.S., Europe, Asia-Pacific and Latin America on national and international mandates that apply to the safety and promotion of drugs and devices. The Center also hosts conferences and educational programs, inviting leading experts from the public and private sectors to examine cutting edge policy issues.
Launched in 2007, the Center extends Seton Hall Law School’s national reputation in health law to the life sciences arena and offers a challenging health law curriculum through its M.S.J., J.D., and LL.M. degree programs, online Graduate Certificates, and online M.S.J. The Center draws upon the intellectual strength of the Seton Hall Law School faculty and research fellows who bring to the Center’s work nationally-recognized expertise in health and pharmaceutical law, not-for-profit governance, intellectual property law and bioethics, among other areas.
Interested in becoming a Grantor or Exhibiting?
Click Here for more information or contact Justin Sorensen at 206-452-0609.